Life sciences and technology companies are increasingly aligning to pursue advances in life science technology that enhance the quality, speed, and sophistication of patient care. However, these advances also introduce new cybersecurity risks and regulatory oversight that must be managed. And, in the COVID-19 era, the use of medical tracking and diagnostic technologies intensifies the need to address such risks.
On our recent webcast, Marsh and leading policy, cybersecurity, and legal authorities discussed how manufacturers, providers, and other health care ecosystem stakeholders can manage these complex cybersecurity and regulatory issues – and protect themselves from potential liabilities.
Disclaimer: Marsh India Insurance Brokers Pvt Ltd is a subsidiary of Marsh McLennan.
Marsh India Insurance Brokers Pvt. Ltd. having corporate and the registered office at 1201-02, Tower 2, One World Center, Plot-841, Jupiter Textile Compound Mills, Senapati Bapat Marg, Elphinstone Road (W), Mumbai 400 013 is registered as a composite broker with Insurance and Regulatory Development Authority of India (IRDAI). Its license no. is 120 and is valid from 03/03/2021 to 02/03/2024. CIN: U66010MH2002PTC138276.